Intercept Pharmaceuticals (ICPT) Short Interest Ratio & Short Volume → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free ICPT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial MediaSustainability Intercept Pharmaceuticals Short Interest DataCurrent Short Volume10,190,000 sharesPrevious Short Volume9,430,000 sharesChange Vs. Previous Month+8.06%Dollar Volume Sold Short$185.46 millionShort Interest Ratio / Days to Cover5.3Last Record DateOctober 15, 2023Outstanding Shares41,830,000 sharesFloat Size33,790,000 sharesShort Percent of Float30.16%Today's Trading Volume0 sharesAverage Trading Volume1,362,029 sharesToday's Volume Vs. Average0% Short Selling Intercept Pharmaceuticals ? Sign up to receive the latest short interest report for Intercept Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatICPT Short Interest Over TimeICPT Days to Cover Over TimeICPT Percentage of Float Shorted Over Time Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Intercept Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202310,190,000 shares $185.46 million +8.1%30.2%5.3 $18.20 9/30/20239,430,000 shares $174.83 million -23.6%27.9%5.5 $18.54 9/15/202312,340,000 shares $141.29 million +18.7%36.5%8.5 $11.45 8/31/202310,400,000 shares $112.63 million +9.2%29.0%10.5 $10.83 8/15/20239,520,000 shares $97.68 million +11.6%26.6%8.7 $10.26 7/31/20238,530,000 shares $92.12 million +14.0%24.1%6.3 $10.80 Get the Latest News and Ratings for ICPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intercept Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/20237,480,000 shares $84.45 million +4.0%21.2%5.5 $11.29 6/30/20237,190,000 shares $79.52 million +12.5%20.4%5.2 $11.06 6/15/20236,390,000 shares $75.53 million +23.6%18.1%5 $11.82 5/31/20235,170,000 shares $54.49 million +61.6%14.7%4.4 $10.54 5/15/20233,200,000 shares $52.64 million No Change9.1%3 $16.45 10/31/20224,170,000 shares $57.84 million +3.7%N/A4.1 $13.87 10/15/20224,020,000 shares $54.47 million -22.1%N/A3.8 $13.55 9/30/20225,160,000 shares $71.98 million +4.0%21.7%4.8 $13.95 9/15/20224,960,000 shares $87.15 million -9.7%20.9%5.2 $17.57 8/31/20225,490,000 shares $95.36 million -52.5%23.2%6.1 $17.37 8/15/202211,560,000 shares $210.28 million +8.4%48.8%12.9 $18.19 7/31/202210,660,000 shares $136.02 million +3.1%45.1%12.6 $12.76 7/15/202210,340,000 shares $149.93 million +15.9%43.8%10.5 $14.50 6/30/20228,920,000 shares $123.19 million -8.6%37.8%9.1 $13.81 6/15/20229,760,000 shares $115.66 million +9.5%41.3%9.9 $11.85 5/31/20228,910,000 shares $161.27 million +2.0%37.7%8.8 $18.10 5/15/20228,740,000 shares $156.27 million +9.4%36.9%8.5 $17.88 4/30/20227,990,000 shares $125.52 million -2.9%33.8%7.9 $15.71 4/15/20228,230,000 shares $135.55 million -0.1%34.8%10.3 $16.47 3/31/20228,240,000 shares $134.06 million -3.1%N/A9.9 $16.27 3/15/20228,500,000 shares $121.21 million -0.7%36.0%10.6 $14.26 2/28/20228,560,000 shares $122.07 million +2.0%36.2%10.2 $14.26 2/15/20228,390,000 shares $133.65 million +0.2%35.7%10.1 $15.93 1/31/20228,370,000 shares $137.18 million -0.1%35.6%10 $16.39 1/15/20228,380,000 shares $148.83 million -0.4%N/A9.2 $17.76 12/31/20218,410,000 shares $137.00 million -2.2%35.7%9.6 $16.29 12/15/20218,600,000 shares $129.77 million +3.1%36.5%10.3 $15.09 11/30/20218,340,000 shares $143.53 million -0.4%34.4%10.5 $17.21 11/15/20218,370,000 shares $147.90 million +11.2%34.5%10.3 $17.67 10/29/20217,530,000 shares $126.96 million -2.7%31.1%7.3 $16.86 10/15/20217,740,000 shares $130.19 million -2.5%28.4%8.5 $16.82 9/30/20217,940,000 shares $117.91 million -6.6%29.2%8.9 $14.85 9/15/20218,500,000 shares $128.18 million +10.4%31.2%9.7 $15.08 8/31/20217,700,000 shares $114.81 million -9.4%28.3%9.3 $14.91My top 100 stocks… (Ad)We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well.Get some cool freebies right here. ICPT Short Interest - Frequently Asked Questions What is Intercept Pharmaceuticals' current short interest? Short interest is the volume of Intercept Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 10,190,000 shares of ICPT short. 30.16% of Intercept Pharmaceuticals' shares are currently sold short. Learn More on Intercept Pharmaceuticals' current short interest. What is a good short interest ratio for Intercept Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ICPT shares currently have a short interest ratio of 5.0. Learn More on Intercept Pharmaceuticals's short interest ratio. Which institutional investors are shorting Intercept Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Intercept Pharmaceuticals: Harvest Management LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Intercept Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 30.16% of Intercept Pharmaceuticals' floating shares are currently sold short. Is Intercept Pharmaceuticals' short interest increasing or decreasing? Intercept Pharmaceuticals saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 10,190,000 shares, an increase of 8.1% from the previous total of 9,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Intercept Pharmaceuticals' float size? Intercept Pharmaceuticals currently has issued a total of 41,830,000 shares. Some of Intercept Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Intercept Pharmaceuticals currently has a public float of 33,790,000 shares. How does Intercept Pharmaceuticals' short interest compare to its competitors? 30.16% of Intercept Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Intercept Pharmaceuticals: Pediatrix Medical Group, Inc. (5.53%), REGENXBIO Inc. (8.30%), Sage Therapeutics, Inc. (18.98%), Enliven Therapeutics, Inc. (18.33%), ALX Oncology Holdings Inc. (13.47%), Relay Therapeutics, Inc. (8.08%), BioLife Solutions, Inc. (6.84%), ARS Pharmaceuticals, Inc. (14.44%), Canopy Growth Co. (13.91%), Tango Therapeutics, Inc. (19.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Intercept Pharmaceuticals stock? Short selling ICPT is an investing strategy that aims to generate trading profit from Intercept Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intercept Pharmaceuticals? A short squeeze for Intercept Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ICPT, which in turn drives the price of the stock up even further. How often is Intercept Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICPT, twice per month. The most recent reporting period available is October, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Pediatrix Medical Group Short Squeeze REGENXBIO Short Squeeze Sage Therapeutics Short Squeeze Enliven Therapeutics Short Squeeze ALX Oncology Short Squeeze Relay Therapeutics Short Squeeze BioLife Solutions Short Squeeze ARS Pharmaceuticals Short Squeeze Canopy Growth Short Squeeze Tango Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ICPT) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets